Possible Role of High-Dose Barbiturates and Early Administration of Parenteral Ketogenic Diet for Reducing Development of Chronic Epilepsy in Febrile Infection-Related Epilepsy Syndrome: A Case Report

Abstract

We describe the efficacy of high-dose barbiturates and early administration of a parenteral ketogenic diet (KD) as initial treatments for acute status epilepticus (SE) in an 8-year-old girl with febrile infection-related epilepsy syndrome (FIRES). The patient was admitted to our hospital with refractory focal SE. Abundant epileptic discharges over the left frontal region were observed on electroencephalogram (EEG). Treatment with continuous infusion of thiamylal for 4 hours, increased incrementally to 40 mg/kg/h, successfully ended the clinical SE, and induced a burst-suppression coma. The infusion rate was then gradually decreased to 4 mg/kg/h over the next 12 hours. Parenteral KD was administered from days 6 to 21 of illness. Continuous infusion of thiamylal was switched to midazolam on day 10 without causing seizures or EEG exacerbations. The patient has remained seizure free in the 15 months since hospital discharge. The effectiveness of KD for the treatment of FIRES has attracted attention amongst clinicians, but KD treatment may need to last for 2 to 4 days before it can stop SE, a time period that could cause irreversible brain damage. Considering the severity of SE in our patient and the dose of barbiturates needed to treat it, we consider this case to have had a good clinical outcome. The results suggest that rapid termination of seizure using high-dose barbiturates in conjunction with early administration of parenteral KD could reduce the development of chronic epilepsy in patients with FIRES.

Keywords

febrile infection-related epilepsy syndrome - epilepsy - barbiturates - ketogenic diet

Ethics Statement

Written informed consent was obtained from the parents of the patient for the publication of this case report.

Financial Support

The authors declare that the research was conducted in the absence of any commercial or financial relationships.

Publication History

Received: 25 April 2020

Accepted: 28 July 2020

Article published online:
23 November 2020

• References

• 1 Hirsch LJ, Gaspard N, van Baalen A. et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018; 59 (04) 739-744
• 2 Kramer U, Chi CS, Lin KL. et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011; 52 (11) 1956-1965
• 3 Howell KB, Katanyuwong K, Mackay MT. et al. Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia 2012; 53 (01) 101-110
• 4 van Baalen A, Vezzani A, Häusler M, Kluger G. Febrile infection-related epilepsy syndrome: clinical review and hypotheses of epileptogenesis. Neuropediatrics 2017; 48 (01) 5-18
• 5 Nabbout R, Mazzuca M, Hubert P. et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010; 51 (10) 2033-2037
• 6 Singh RK, Joshi SM, Potter DM, Leber SM, Carlson MD, Shellhaas RA. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014; 134 (05) e1431-e1435
• 7 Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS. CHEESE Study Group. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol 2015; 52 (04) 442-445
• 8 Strzelczyk A, Reif PS, Bauer S. et al. Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus. Seizure 2013; 22 (07) 581-583
• 9 Peng P, Peng J, Yin F. et al. Ketogenic diet as a treatment for super-refractory status epilepticus in febrile infection-related epilepsy syndrome. Front Neurol 2019; 10: 423
• 10 Trinka E, Cock H, Hesdorffer D. et al. A definition and classification of status epilepticus--report of the ILAE task force on classification of status epilepticus. Epilepsia 2015; 56 (10) 1515-1523
• 11 Byun JI, Chu K, Sunwoo JS. et al. Mega-dose phenobarbital therapy for super-refractory status epilepticus. Epileptic Disord 2015; 17 (04) 444-452
• 12 Chiusolo F, Diamanti A, Bianchi R. et al. From intravenous to enteral ketogenic diet in PICU: a potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol 2016; 20 (06) 843-847